Study of Tau Imaging With the Use of [18F]MK-6240 Tracer
Status:
Recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
The recent development of a PET tracer,[18F]MK-6240(an[18F]tau imaging
agent,CerveauTechnologies)that has high affinity for the human phosphorylated tau deposits in
AD brain offers new opportunities to investigate tau pathology. The investigators will
evaluate this imaging agent in individuals from families with a known Autosomal Dominant
Alzheimer's Disease (ADAD) mutation. This study of tau PET using [18F]MK-6240 is performed in
conjunction with DIAN and DIAN Extended Registry (DIAN-EXR).
Details
Lead Sponsor:
Tammie L. S. Benzinger, MD, PhD Washington University School of Medicine